CLINICAL CHARACTERISTICS AND RISK FACTORS OF PEOPLE WITH NEWLY DIAGNOSED TYPE 2 DIABETES AND WITH DYSLIPIDEMIA
Main Article Content
Abstract
The study aimed to find the answers to insulin resistance in people with type 2 diabetes with dyslipidemia in Vietnam to provide better knowledge of control and treatment. 163 patients with type 2 diabetes diagnosed for the first time, among them 95 (58%) patients with dyslipidemia, and 53 subjects were recruited as the control. Data collection through clinical examination, blood lipid, insulin, C-peptide tests. The results showed that the mean age at diagnosis of diabetes was 53.8 ± 12.2 (53.0 ± 13.6 for female; 54.6 ± 10.7 for male). The index of insulin, C-peptide, TC, TG, and LDL-C of the group of diabetes without dyslipidemia wá significantly lower than those with dyslipidemia. Thus, insulin resistance and dyslipidemia should be considered during treatment.
Article Details
Keywords
type 2 diabetes mellitus, dyslipidemia, insulin resistance
References
2. Tạ Văn Bình (2006), Bệnh đái tháo đường- Tăng glucose máu. Nhà xuất bản Y học.
3. Lưu Cảnh Toàn (2006), Nghiên cứu tình trạng kháng insulin và chức năng tế bào β ở bệnh nhân ĐTĐ týp 2 có tăng huyết áp. Luận văn thạc sỹ y học - Học viện Quân y.
4. American Diabetes Association (1997), Report of the expert committee on the diagnosis and classification of Diabetes Mellitus. Diabetes care, p.1184-1195.
5. Foster Daniel W. (1991), Harrison’s principle of internal medicine. International edition V2, 1991, p.1739-1757.
6. John K. Davidson, Clinical Diabetes Mellitus. Third Edition. A problem oriented opproach, p.354-355.
7. Matthews (2001), Insulin resistance and beta-cell function – a clinical perspective, Diabetes. Obesity and Metabolism. 3 (Suppl. 1): S28-S33.
8. Zierath J.R., Handberg A., Tally M., Wallberg- Henriksson H. (1996), C-peptid stimulates glucose transport in isolated skeletal muscle independent of insulin receptor and tyrosin kinase activation. Diabetologia, 39:306-313.
9. Zimmet P. (2001), Epidemiology, Evidence for prevention typ2 diabetes. The epidemiology of diabetes mellitus, p.41.